logoOmicsDI
  • Browse
  • Submit Data
  • Databases
  • API

4 Results

Show all   Save search   Copy query

Show results for

  • UnknownUnknown (4)

Publication Date

Release Date

  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
UnknownEfficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study.
Not available
S-EPMC9209617 | biostudies-literature
UnknownEfficacy and Safety of Bimekizumab in Japanese Patients with Generalised Pustular Psoriasis and Erythrodermic Psoriasis: 3-Year Results from BE BRIGHT, a Multicentre, Open-Label, Phase 3 Study.
Not available
S-EPMC12454709 | biostudies-literature
UnknownExploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study.
Not available
S-EPMC11264648 | biostudies-literature
UnknownUnmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line.
Not available
S-EPMC8850517 | biostudies-literature
  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
OmicsDI is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

EMBL-EBI logoEMBL-EBI logo

OmicsDI Databases

  • PRIDE
  • PeptideAtlas
  • MassIVE
  • JPOST Repository
  • Physiome Model Repository
  • EGA
  • EVA
  • ENA
  • LINCS
  • PAXDB
  • Cell Collective
  • MetaboLights
  • Metabolomics Workbench
  • MetabolomeExpress
  • GNPS
  • BioModels
  • FAIRDOMHub
  • ArrayExpress
  • dbGaP
  • ExpressionAtlas
  • GEO
  • NODE

Information

  • Databases
  • Help
  • API
  • Contact us
  • Code on GitHub
  • Terms of use
  • Submit Data